Publications in collaboration with researchers from Hospital de Jerez (1)

2016

  1. Myopodin methylation is a prognostic biomarker and predicts antiangiogenic response in advanced kidney cancer

    Tumor Biology, Vol. 37, Núm. 10, pp. 14301-14310